Internal Medicine, Gastroenterology · Boston, MA
NPI
1235161779
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
133 Brookline Ave
Boston, MA, 02215
Phone (617) 421-1091
Groups this clinician bills Medicare through
Medicare paid, 2024
$218K
3,029 services
Medicare patients, 2024
492
Average age 72
Drug cost, 2024
$340K
1,423 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Irena Maier was code 45380 (lower gi endoscopy - other), 265 times for 265 patients. In total Irena Maier billed 3,029 services in 84 codes, and Medicare paid $218K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-01-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 45380 Lower GI Endoscopy - Other | Office | 265 | 265 | $244.93 | $65K |
| 45385 Colonoscopy - Lesion Removal | Office | 145 | 145 | $404.82 | $59K |
| 36415 Venipuncture Blood Collection | Office | 130 | 73 | $8.65 | $1,125 |
| 80076 Clinical Chemistry | Office | 75 | 42 | $8.01 | $601 |
| 85025 Blood Count | Office | 65 | 50 | $7.61 | $495 |
| 82565 Clinical Chemistry | Office | 61 | 39 | $5.02 | $306 |
| 43239 Upper GI Endoscopy | Office | 59 | 59 | $248.63 | $15K |
| 99213 Office E&M - Established | Office | 47 | 40 | $67.68 | $3,181 |
| 86140 Clinical Chemistry | Office | 46 | 30 | $5.08 | $234 |
| 85027 Blood Count | Office | 45 | 25 | $6.34 | $285 |
| 85610 Clinical Chemistry | Office | 36 | 24 | $4.20 | $151 |
| 82948 Clinical Chemistry | Office | 34 | 33 | $4.94 | $168 |
| 83540 Clinical Chemistry | Office | 28 | 17 | $6.34 | $178 |
| 45380 Lower GI Endoscopy - Other | Facility | 28 | 28 | $143.16 | $4,008 |
| 84466 Clinical Chemistry | Office | 28 | 17 | $12.50 | $350 |
By year: 2022 $240K for 5,117 services; 2023 $249K for 6,138 services; 2024 $218K for 3,029 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 130 | 73 | $8.65 | $1,125 |
| 80076 Clinical Chemistry | 75 | 42 | $8.01 | $601 |
| 85025 Blood Count | 65 | 50 | $7.61 | $495 |
| 82565 Clinical Chemistry | 61 | 39 | $5.02 | $306 |
| 86140 Clinical Chemistry | 46 | 30 | $5.08 | $234 |
| 85027 Blood Count | 45 | 25 | $6.34 | $285 |
| 85610 Clinical Chemistry | 36 | 24 | $4.20 | $151 |
| 82948 Clinical Chemistry | 34 | 33 | $4.94 | $168 |
| 83540 Clinical Chemistry | 28 | 17 | $6.34 | $178 |
| 84466 Clinical Chemistry | 28 | 17 | $12.50 | $350 |
Medicare prescription drug claims, 2024
In 2024, the drug Irena Maier prescribed most often to Medicare patients was Omeprazole, with 172 prescriptions and refills. In total Irena Maier wrote 1,423 Medicare prescriptions that cost $340K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Omeprazole Generic | 172 | 405 | 65 | $2,696 |
| Gavilyte-C Peg3350/Sod Sulf,bicarb,cl/Kcl | 168 | 168 | 161 | $2,939 |
| Peg3350-Sod Sul-Nacl-Kcl-Asb-C Peg3350/Sod Sul/Nacl/Kcl/Asb/C | 160 | 160 | 155 | $11K |
| Famotidine Generic | 140 | 327 | 48 | $2,210 |
| Pantoprazole Sodium Generic | 113 | 219 | 39 | $2,049 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 70 | 70 | 69 | $4,315 |
| Mesalamine Generic | 59 | 121 | 17 | $38K |
| Linzess Linaclotide | 32 | 44 | 12 | $23K |
| Dicyclomine Hcl Generic | 32 | 46 | 13 | $659 |
| Esomeprazole Magnesium Generic | 26 | 60 | Under 11 | $1,458 |
| Creon Lipase/Protease/Amylase | 26 | 39 | Under 11 | $48K |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 25 | 25 | 25 | $310 |
| Sucralfate Generic | 24 | 24 | 11 | $3,133 |
| Colestipol Hcl Generic | 22 | 44 | Under 11 | $3,396 |
| Ondansetron Hcl Generic | 19 | 19 | 17 | $28.73 |
Brand drugs: 226 claims; generic drugs: 1,197 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Irena Maier were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.